Search Results - "Gurley, K E"

Refine Results
  1. 1

    p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent by KEMP, Christopher J, SHAOLI SUN, GURLEY, Kay E

    Published in Cancer research (Chicago, Ill.) (2001)
    “…The p53 protein rapidly accumulates in cells in response to DNA damage, which can trigger apoptosis. This pathway is hypothesized to be important for tumor…”
    Get full text
    Journal Article
  2. 2

    ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma by Busch, S E, Moser, R D, Gurley, K E, Kelly-Spratt, K S, Liggitt, H D, Kemp, C J

    Published in Oncogene (15-05-2014)
    “…Non-small-cell lung carcinoma (NSCLC) is among the deadliest of human cancers. The CDKN2A locus, which houses the INK4a and ARF tumor suppressor genes, is…”
    Get full text
    Journal Article
  3. 3

    p53 induction, cell cycle checkpoints, and apoptosis in DNAPK- deficient scid mice by Gurley, Kay E., Kemp, Christopher J.

    Published in Carcinogenesis (New York) (01-12-1996)
    “…The p53 tumor suppressor protein is rapidly induced following treatment of cells with agents which cause DNA double strand breaks (dsbs) leading to cell cycle…”
    Get full text
    Journal Article
  4. 4

    Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody by Nicolls, M R, Aversa, G G, Pearce, N W, Spinelli, A, Berger, M F, Gurley, K E, Hall, B M

    Published in Transplantation (01-03-1993)
    “…Monoclonal antibodies to CD3 have been shown to activate T cells in vivo and in vitro but have also been shown to render T cells anergic in vitro. In this…”
    Get more information
    Journal Article
  5. 5

    DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice by GURLEY, K. E, KHOA VO, KEMP, C. J

    Published in Cancer research (Chicago, Ill.) (15-07-1998)
    “…The tumor-suppressing phenotype of p53 is thought to be due to its accumulation in response to DNA damage and resultant cell cycle arrest or apoptosis…”
    Get full text
    Journal Article
  6. 6

    Resistance to skin tumorigenesis in DNAPK-deficient SCID mice is not due to immunodeficiency but results from hypersensitivity to TPA-induced apoptosis by Kemp, Christopher J., Vo, Khoa, Gurley, Kay E.

    Published in Carcinogenesis (New York) (01-11-1999)
    “…Scid/scid mice have a mutation in the gene encoding the catalytic subunit of DNA-dependent protein kinase (DNAPKcs) and are defective in end joining of DNA…”
    Get full text
    Journal Article
  7. 7

    Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer by Kelly-Spratt, K S, Philipp-Staheli, J, Gurley, K E, Hoon-Kim, K, Knoblaugh, S, Kemp, C J

    Published in Oncogene (15-10-2009)
    “…Reduced expression of the CDK inhibitor p27 Kip1 (p27) in human lung cancer correlates with tumor aggressiveness and poor prognosis. However, the regulation of…”
    Get full text
    Journal Article
  8. 8

    Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III: Further characterization of the CD4+ suppressor cell and its mechanisms of action by HALL, B. M, PEARCE, N. W, GURLEY, K. E, DORSCH, S. E

    “…The cellular basis of the specific unresponsiveness that develops in DA rats treated with cyclosporine (CSA) for 10 d after grafting a PVG heart was examined…”
    Get full text
    Journal Article
  9. 9

    Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains by Ilano, AL, McConnell, MV, Gurley, KE, Spinelli, A, Pearce, NW, Hall, BM

    Published in The Journal of immunology (1950) (01-11-1989)
    “…MRC OX35, an anti-CD4 mAb, was used to treat high responder Wistar Furth (W/F) (RT1u) and low responder DA (RT1a) rats which had been grafted with directly…”
    Get full text
    Journal Article
  10. 10

    Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts by Pearce, N W, Berger, M F, Gurley, K E, Spinelli, A, Hall, B M

    Published in Transplantation (01-02-1993)
    “…DA rats treated with a short course of cyclosporine develop specific unresponsiveness to RT1-incompatible PVG donor heart allografts. CD4+ cells, not CD8+…”
    Get more information
    Journal Article
  11. 11

    Induction of tolerance to heart allografts in rats using posttransplant total lymphoid irradiation and anti-T cell antibodies by Woodley, S L, Gurley, K E, Hoffmann, S L, Nicolls, M R, Hagberg, R, Clayberger, C, Holm, B, Wang, X, Hall, B M, Strober, S

    Published in Transplantation (01-12-1993)
    “…This study examined whether posttransplant anti-T cell monoclonal or polyclonal antibody therapy could provide a window of treatment to allow posttransplant…”
    Get more information
    Journal Article
  12. 12

    Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells by Pearce, NW, Spinelli, A, Gurley, KE, Dorsch, SE, Hall, BM

    Published in The Journal of immunology (1950) (15-07-1989)
    “…In DA rats grafted with PVG hearts, the injection of 1 ml of Wistar-Furth x DA)F1 anti-PVG serum on the day of grafting prevents rejection and induces a state…”
    Get full text
    Journal Article
  13. 13

    Immune mechanisms in organ allograft rejection. I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection by Lowry, R P, Gurley, K E, Forbes, R D

    Published in Transplantation (01-10-1983)
    “…Sublethally irradiated (780 rads) rats receiving fully allogeneic heart transplants were reconstituted with sensitized lymphocytes fractionated into helper and…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Immune mechanisms in organ allograft rejection. II. T helper cells, delayed-type hypersensitivity, and rejection of renal allografts by Gurley, K E, Lowry, R P, Forbes, R D

    Published in Transplantation (01-10-1983)
    “…The cellular requirements for renal allograft rejection have been assessed by adoptive transfer studies in a rat model. Sublethally irradiated (780 rads) LEW…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. II. Sequential changes in alloreactivity of T cell subsets by Hall, B M, Gurley, K E, Pearce, N W, Dorsch, S E

    Published in Transplantation (01-06-1989)
    “…A 10-day course of cyclosporine treatment inhibits the capacity of DA rats to reject PVG heart grafts and leads to the development of specific unresponsiveness…”
    Get more information
    Journal Article
  18. 18

    The murine gene p27Kip1 is haplo-insufficient for tumour suppression by FERO, M. L, RANDEL, E, GURLEY, K. E, ROBERTS, J. M, KEMP, C. J

    Published in Nature (London) (12-11-1998)
    “…p27Kip is a candidate human tumour-suppressor protein, because it is able to inhibit cyclin-dependent kinases and block cell proliferation. Abnormally low…”
    Get full text
    Journal Article
  19. 19
  20. 20